Comparison of baseline and follow-up factors in HBV/HCV dually infected patients who did achieve HBsAg seroconversion versus HBsAg seroclearance without seroconversion and non-HBsAg seroclearance.

HBsAg, hepatitis B s antigen; SD, standard deviation; ALT, alanine aminotransferase; HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; SVR, sustained virologic response; EOT, end of treatment.